-
Imaging Findings in Cardiovascular Involvements of IgG4 Related Disease: A Systematic Review Study Rheumatology (IF 4.7) Pub Date : 2024-09-14 Amir Ghaffari Jolfayi, Alireza Salmanipour, Kiyan Heshmat-Ghahdarijani, Shahla Meshgi, Maedeh Dastmardi, Ghazaleh Salehabadi, Amir Azimi, MohammadHossein MozafaryBazargany, Peyvand Parhizkar Roudsari, Behnaz Mahmoodiyeh, Ali Mohammadzadeh
Background Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition characterized by IgG4-positive plasma cell infiltration that can affect multiple organs, including the cardiovascular system. The diagnosis of IgG4-RD relies on a combination of clinical, serological, radiological, and pathological findings. However, due to the varied and insidious clinical presentations, normal
-
Novel deep-learning analysis for connective tissue disease -related interstitial lung disease extent assessment on CT: a preliminary cross-sectional study Rheumatology (IF 4.7) Pub Date : 2024-09-14 Yuhei Ito, Yasutaka Ichikawa, Shuichi Murashima, Hajime Sakuma, Tae Iwasawa, Yoshiyuki Arinuma, Ayako Nakajima
Objectives Physician’s evaluation of interstitial lung disease (ILD) extension with high-resolution computed tomography (HRCT) has limitations such as lack of objectivity and reproducibility. This study aimed to investigate the utility of computer-based deep-learning analysis using QZIP-ILD® software (DL-QZIP) compared with conventional approaches in connective tissue disease (CTD) -related ILD. Methods
-
Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study Rheumatology (IF 4.7) Pub Date : 2024-09-13 Luisa Ojeda-Fernandez, Stefania Calvisi, Ginevra Torrigiani, Mauro Tettamanti, Ida Fortino, Carla Roncaglioni, Marta Baviera
Objectives Current data on arterial and venous thrombotic events (ATE & VTE) and cardiovascular (CV) risk management in European systemic lupus erythematosus (SLE) population are limited. This study aimed to investigate the incidence and risk of thrombotic events and all-cause death in an Italian SLE cohort over the past decade, along with its pharmacotherapy. Methods Incident SLE cases between 2010
-
Ultrasonography led multimodal diagnostic pathway for giant cell arteritis Rheumatology (IF 4.7) Pub Date : 2024-09-13 Chetan B Mukhtyar, Clare Beadsmoore, Georgina Ducker, Sarah Fordham, Katherine Sisson, Colin Jones
Objectives To establish the sensitivity and negative predictive value of a multimodal pathway incorporating ultrasonography, 18-fluorodeoxyglucose labelled positron emission tomography computed tomography and temporal artery biopsy for the diagnosis of giant cell arteritis. Methods 1000 consecutive referrals for a new diagnosis of giant cell arteritis were analysed. All patients had a protocolized
-
Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: A nationwide cross-sectional study among > 12,000 patients Rheumatology (IF 4.7) Pub Date : 2024-09-11 Sofie Bech Vestergaard, Bente Appel Esbensen, Julie Midtgaard, Pernille Fevejle Cromhout, Mette Aadahl, Bente Glintborg, Annette de Thurah
Objectives To investigate the prevalence of loneliness among patients with IA with a specific focus on the associations with disease activity and impact. Methods We used data from a Danish cross-sectional survey comprising information on socio-demographics, mental health status, and social contacts among 12 713 patients with IA (rheumatoid arthritis (RA)/psoriatic arthritis (PsA)/axial spondylarthritis
-
Clinical spectrum and outcome of children with deficiency of adenosine deaminase 2 (DADA2): multicentric experience from India Rheumatology (IF 4.7) Pub Date : 2024-09-11 Sathish Kumar, Akagri Chugh, Samantha Cheryl Kumar, Anu Punnen, Chandrika Bhat, Pratap Patra, Vijay Viswanathan, Aditya Gupta, Mukul Aggarwal, Amiya Ranjan Nayak, Lokesh Lingappa, Jyoti Sharma, Neerja Gupta, Priyanka Naranje, Manisha Jana, Narendra Kumar Bagri, Pankaj Hari, Athimalaipet V Ramanan
Objectives Deficiency of adenosine deaminase-2 (DADA2) is a monogenic disorder closely resembling polyarteritis nodosa (PAN) and can present to physicians across various specialties. Through this case series, we aim to describe the clinical spectrum and outcome of Indian children with DADA2. We aimed to study the clinical spectrum and outcome of Indian children with DADA-2. Methods The deidentified
-
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis Rheumatology (IF 4.7) Pub Date : 2024-09-11 Christopher P Denton, Enrico De Lorenzis, Elen Roblin, Nina Goldman, Begonya Alcacer-Pitarch, Emma Blamont, Maya H Buch, Maresa Carulli, Caroline Cotton, Francesco Del Galdo, Emma Derrett-Smith, Karen Douglas, Sue Farrington, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane Herrick, Michael Hughes, Clare Pain, Georgina Pantano, John D Pauling, Athiveeraramapandian Prabu, Nuala O’Donoghue, Elisabetta
This guideline was developed according to the British Society for Rheumatology Guidelines Protocol by a Guideline Development Group comprising healthcare professionals with expertise in SSc and people with lived experience, as well as patient organization representatives. It is an update of the previous 2015 SSc guideline. The recommendations were developed and agreed by the group and are underpinned
-
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary Rheumatology (IF 4.7) Pub Date : 2024-09-11 Christopher P Denton, Enrico De Lorenzis, Elen Roblin, Nina Goldman, Begonya Alcacer-Pitarch, Emma Blamont, Maya H Buch, Maresa Carulli, Caroline Cotton, Francesco Del Galdo, Emma Derrett-Smith, Karen Douglas, Sue Farrington, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane Herrick, Michael Hughes, Clare Pain, Georgina Pantano, John D Pauling, Athiveeraramapandian Prabu, Nuala O’Donoghue, Elisabetta
This guideline was developed according to the British Society for Rheumatology Guidelines Protocol by a Guideline Development Group comprising healthcare professionals with expertise in SSc and people with lived experience, as well as patient organization representatives. It is an update of the previous 2015 SSc guideline. The recommendations were developed and agreed by the group and are underpinned
-
Majeed syndrome: first description in a patient of central-European ancestry Rheumatology (IF 4.7) Pub Date : 2024-09-10 Enrico Drago, Arinna Bertoni, Alice Grossi, Maria Beatrice Damasio, Lorenzo Anfigeno, Maurizio Miano, Riccardo Papa, Stefano Volpi, Isabella Ceccherini, Marco Gattorno, Roberta Caorsi
OBJECTIVES We present the first case of a Majeed syndrome in a girl of central-European ancestry. METHODS : Patient’s medical records were reviewed. A NGS panel for autoinflammatory diseases was performed and the mutation was confirmed by Sanger analysis. Freshly isolated monocytes were activated with LPS +/- ATP. The concentration of inflammatory cytokines was assessed in monocytes supernatants. RESULTS
-
Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus Rheumatology (IF 4.7) Pub Date : 2024-09-09 Masao Katsushima, Yoichi Nakayama, Tsuneyasu Yoshida, Yuri Nishida, Mirei Shirakashi, Ran Nakashima, Hajime Yoshifuji, Shinji Ito, Junko Satoh, Masaki Yamamoto, Ryu Watanabe, Takashi Emori, Tomonori Kamiya, Yuko Nitahara, Yu Nakagama, Naoko Ohtani, Yasutoshi Kido, Akio Morinobu, Motomu Hashimoto
Objective Bacterial translocation across the gut barrier has been implicated in the pathogenesis of systemic lupus erythematosus (SLE), though underlying mechanisms remain unclear. This study aimed to investigate the role of translocated bacteria in the context of molecular mimicry by utilizing lupus model mice and blood samples from untreated SLE patients. Methods Bacterial translocation was evaluated
-
Gastrointestinal dysmotility is associated with proton pump inhibitor refractory esophagitis in patients with systemic sclerosis Rheumatology (IF 4.7) Pub Date : 2024-09-09 Luis G Alcala-Gonzalez, Alfredo Guillen del-Castillo, Ariadna Aguilar Cayuelas, Claudia Barber Caselles, Claudia Codina-Clavaguera, Antonio Marin García, Jordi Serra, Carolina Malagelada, Carmen P Simeón-Aznar
Objectives Patients with systemic sclerosis present with severe gastroesophageal reflux disease, often refractory to proton-pump inhibitors (PPI) treatment. The aim of the present study was to identify factors associated with PPI-refractory esophagitis. Methods We performed a cross-sectional study in a single-center cohort of patients diagnosed with systemic sclerosis. We included patients who underwent
-
Normative data on lower extremity entheseal tendon thicknesses in healthy children: an ultrasound study correlating age, sex, anthropometry Rheumatology (IF 4.7) Pub Date : 2024-09-09 Şeyma Türkmen, Serap Ata, Kadir Ulu, Betül Sözeri
Objectives This study aims to establish normative data on lower extremity entheseal tendon thicknesses in healthy children and examine correlations with age, gender, and anthropometric measures using musculoskeletal ultrasound. The secondary objective of the study is to investigate the power Doppler properties of entheseal tendons. Methods A total of 192 healthy children, aged 5–18 years, participated
-
An objective diagnosis of gout and calcium pyrophosphate deposition disease with machine learning of Raman spectra acquired in a point-of-care setting Rheumatology (IF 4.7) Pub Date : 2024-09-02 Tom Niessink, Tim L Jansen, Frank A W Coumans, Tim J M Welting, Matthijs Janssen, Cees Otto
Objective Raman spectroscopy is proposed as a next-generation method for the identification of monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals in synovial fluid. As the interpretation of Raman spectra requires specific expertise, the method is not directly applicable for clinicians. We developed an approach to demonstrate that the identification process can be automated with the use
-
Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies Rheumatology (IF 4.7) Pub Date : 2024-09-02 XingYao Wang, Jemima Albayda, Julie J Paik, Eleni Tiniakou, Brittany Adler, Andrew L Mammen, Lisa Christopher-Stine, Christopher A Mecoli
Objective This study aims to evaluate the diagnostic accuracy of CA-125 and PET/CT in detecting cancer among adult patients with idiopathic inflammatory myopathy (IIM). Methods We conducted a retrospective study of a single-centre cohort of adult IIM patients enrolled from 2003 to 2020. Data on CA-125 and PET/CT tests conducted within five years of IIM symptom onset were extracted from electronic medical
-
Association between interleukin-12 p40 subunit and risk of primary Sjögren’s syndrome: a Mendelian randomization study Rheumatology (IF 4.7) Pub Date : 2024-09-02 Benjamin P Zuckerman, Zijing Yang, Alasdair Warwick, Chris Wincup, Mark Russell, James B Galloway, Sizheng Steven Zhao
Objectives Interleukin-12 (IL-12) signalling was proposed in the immunopathogenesis of primary Sjögren’s disease. The efficacy of therapies targeting this pathway is currently unclear. Herein, we investigated the associations between circulating proteins involved in the IL-12 and IL-23 signalling pathways on primary Sjögren’s disease using mendelian randomization. Methods We selected SNPs from protein
-
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease Rheumatology (IF 4.7) Pub Date : 2024-09-02 Sangmee Sharon Bae, Daniela Markovic, Didem Saygin, Daniel Sullivan, Koichi Yamaguchi, Siamak Moghadam-Kia, Chester V Oddis, Fereidoun Abtin, Grace Hyun J Kim, Galina Marder, Swamy Venuturupalli, Paul F Dellaripa, Sonye Danoff, Tracy Doyle, Gary Hunninghake, Joyce S Lee, Jeremy Falk, Cheilonda Johnson, Jonathan Goldin, Donald Tashkin, Christina Charles-Schoeman, Rohit Aggarwal
Objective The 6-min walk test (6MWT) is a simple test widely used to assess sub-maximal exercise capacity in chronic respiratory diseases. We explored the relationship of 6-min walk distance (6MWD) with measurements of physiological, clinical, radiographic measures in patients with myositis-associated interstitial lung disease (MA-ILD). Method We analyzed data from the Abatacept in Myositis Associated
-
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis Rheumatology (IF 4.7) Pub Date : 2024-09-02 Josef S Smolen, Peter C Taylor, Yoshiya Tanaka, Tsutomu Takeuchi, Motomu Hashimoto, Carlos Cara, Bernard Lauwerys, Nicola Tilt, Baran Ufuktepe, Ricardo M Xavier, Alejandro Balsa, Jeffrey R Curtis, Ted R Mikuls, Michael Weinblatt
Objectives To assess the impact of baseline RF level on drug concentrations and efficacy of certolizumab pegol [CZP; TNF inhibitor (TNFi) without a crystallizable fragment (Fc)] and adalimumab (ADA; Fc-containing TNFi) in patients with RA. Methods The phase 4 EXXELERATE study (NCT01500278) was a 104-week, randomized, single-blind (double-blind until week 12; investigator-blind thereafter), head-to-head
-
Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis Rheumatology (IF 4.7) Pub Date : 2024-08-30 J Perin, M Hughes, C A Mecoli, J J Paik, A C Gelber, F M Wigley, L K Hummers, A A Shah, S L Zeger, Z H McMahan
Objectives Systemic sclerosis (SSc) is heterogeneous in its clinical presentation. Common manifestations cluster together, defining unique subgroups. This investigation aims to characterize gastrointestinal (GI) phenotypes and determine whether they can be distinguished by temporal progression. Methods We examine a well-established SSc patient cohort with a modified Medsger GI severity score measured
-
Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-center prospective observational study of decentralized remote vs. traditional clinic enrollment Rheumatology (IF 4.7) Pub Date : 2024-08-29 Shiri Keret, Raisa Lomanto Silva, Tanya Chandra, Eugenia Gkiaouraki, Nantakarn Pongtarakulpanit, Shreya Sriram, Siamak Moghadam-Kia, Chester V Oddis, Rohit Aggarwal
Objectives Idiopathic Inflammatory Myopathies (IIM) are rare and characterized by heterogeneous manifestations and clinical trajectories. Utilizing tele-research methods has the potential to improve participant recruitment and advance the understanding of the disease. We aimed to evaluate disease characteristics in IIM patients throughout the U.S. and compare these parameters between patients recruited
-
Placental lesions in systemic lupus erythematosus pregnancies associated with small for gestational age infants Rheumatology (IF 4.7) Pub Date : 2024-08-28 Rashmi Dhital, Marni Jacobs, Chelsey J F Smith, Mana M Parast
Objectives Up to a quarter of pregnant individuals with systemic lupus erythematosus (SLE) have small for gestational age (SGA) infants. We aimed to characterize placental pathology associated with SGA infants in SLE. Methods We retrospectively analyzed SLE deliveries with placental analysis at UCSD from 11/2018–10/2023, comparing SLE pregnancies resulting in SGA to those that did not, and additionally
-
Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization study Rheumatology (IF 4.7) Pub Date : 2024-08-27 Maja S Kragsnaes, Nickolaj Risbo, Jens Kristian Pedersen, Niels Obel, Axel Finckh, Alma B Pedersen, Torkell Ellingsen
Objectives To describe antibiotic use in patients with inflammatory arthritis (IA) and in the background population (BP) within one year before and after IA diagnosis. Methods Using data from Danish nationwide registries, we identified all adults with a first-time diagnosis of RA, PsA, or AS/spondyloarthritis (AS/SpA) from 2010 through 2018. For each IA patient, we randomly sampled 10 persons from
-
The use of intravenous methylprednisolone in giant cell arteritis—a population-based study Rheumatology (IF 4.7) Pub Date : 2024-08-24 Hampus Henningson, Björn Hammar, Aladdin J Mohammad
Objectives To determine clinical characteristics, outcome, and occurrence of comorbidities in patients with biopsy-confirmed giant cell arteritis (GCA) treated with intravenous methylprednisolone (IVMP) vs those receiving oral glucocorticoids (OGC) only. Methods A retrospective study included patients with GCA diagnosed from 2004 through 2019. Clinical and laboratory characteristics, and cumulative
-
Comparative B cell epitope profiling in Japanese and North American cohorts of MDA5+ dermatomyositis reveals a direct association between immune repertoire and pulmonary mortality Rheumatology (IF 4.7) Pub Date : 2024-08-24 Koichi Yamaguchi, Paul Poland, Lei Zhu, Siamak Moghadam-Kia, Rohit Aggarwal, Toshitaka Maeno, Akihiko Uchiyama, Sei-ichiro Motegi, Chester V Oddis, Dana P Ascherman
Objectives Anti-melanoma differentiation-associated gene 5 antibody-positive (MDA5+) dermatomyositis patients exhibit clinical features that vary by geographical and ethnic/genetic distribution. We therefore investigated whether B cell epitope profiles and corresponding clinical features distinguished two independent cohorts of MDA5+ dermatomyositis. Methods We used ELISA-based methods to determine
-
Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica–a repeated imaging study Rheumatology (IF 4.7) Pub Date : 2024-08-24 Andreas Wiggers Nielsen, Ellen-Margrethe Hauge, Ib Tønder Hansen, Berit Dalsgaard Nielsen, Søren Geill Kjær, Jesper Blegvad, Kate Rewers, Christian Møller Sørensen, Lars Christian Gormsen, Kresten Krarup Keller
Objective The objective was to investigate the incidence of late-onset giant cell arteritis (GCA) within the first year in patients diagnosed with polymyalgia rheumatica (PMR). Methods In this prospective study, treatment-naïve individuals with a new clinical diagnosis of PMR and without GCA symptoms underwent baseline assessments, including vascular ultrasonography and 2-[18F]fluoro-2-deoxy-D-glucose
-
Serine protease inhibitor E2 protects against cartilage tissue destruction and inflammation in osteoarthritis by targeting NF-κB signaling Rheumatology (IF 4.7) Pub Date : 2024-08-24 Linzhu Wang, Shuangshuang Chen, Huizhen Zhang, Guozhao Wei, Fenghua Ma, Mingxiu Zhang, Boyang Zhang, Sen Yang, Hongyi Cheng, Ruonan Yang, Ruifeng Wang, Mengyuan Liu, Yang Song, Xuelian Li, Xiaoqiang E
Objective Osteoarthritis (OA) is a chronic disease characterized by cartilage degeneration and inflammation, with no approved disease-modifying drugs. This study aimed to identify pathogenic genes and elucidate their mechanism in OA. Methods We systematically identified pathogenic genes combined sing-cell and bulk transcriptome profiles of cartilage tissues in OA. Adenovirus carrying the serpin peptidase
-
Acute kidney injury, an underrecognized feature of VEXAS syndrome Rheumatology (IF 4.7) Pub Date : 2024-08-23 Kambiz Kalantari, Megan M Sullivan, Loren P Herrera Hernandez, Lihong Bu, Lynn D Cornell, Samih H Nasr, Fernando C Fervenza, Daniel Montes, Abhishek A Mangaonkar, Ronald S Go, Yael N Kusne, Mrinal M Patnaik, Terra L Lasho, Horatiu Olteanu, Kaaren K Reichard, Kenneth J Warrington, Matthew J Koster
Objectives VEXAS syndrome is an autoinflammatory disease caused by somatic mutation of UBA1 and affects multiple organ systems. Involvement of the kidneys is not well characterized. We aimed to investigate the incidence, risk factors and histopathologic features of acute kidney injury (AKI) in VEXAS syndrome. Methods Patients with genetically confirmed UBA1 mutation consistent with VEXAS were included
-
Rheumatoid arthritis and the risk of ischemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register study Rheumatology (IF 4.7) Pub Date : 2024-08-22 Anne M Kerola, Eirik Ikdahl, Ingrid Engebretsen, Christoffer Bugge, Anne Grete Semb
Objectives Rheumatoid arthritis (RA) patients have an increased risk for cardiovascular diseases, including atrial fibrillation (AF), but the impact of RA on ischemic stroke risk in the context of AF remains unknown. We explored whether the risk of ischemic stroke after diagnosis of AF is further increased among patients with RA compared with non-RA patients. Methods In the nationwide Norwegian Cardio-Rheuma
-
Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland Rheumatology (IF 4.7) Pub Date : 2024-08-22 Daphne Theresa Chia, Andoni Toms, Anish Sanghrajka, Athimalaipet Ramanan, Orla G Killeen, Cristina Ilea, Kamran Mahmood, Sandrine Compeyrot-Lacassagne, Kathryn Bailey, Neil Martin, Kate Armon, Chenqu Suo
Objectives Chronic Recurrent Multifocal Osteomyelitis (CRMO), also known as chronic nonbacterial osteomyelitis (CNO), is a rare autoinflammatory condition affecting the bones in children and teenagers. The actual incidence of CRMO remains uncertain. The objective of this study is to identify the incidence of CRMO in children and young people under the age of 16 years in the United Kingdom (UK) and
-
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis Rheumatology (IF 4.7) Pub Date : 2024-08-22 Giovanni Adami, Riccardo Bixio, Giulia Virelli, Isotta Galvagni, Francesca Mastropaolo, Andrea Morciano, Francesca Ruzzon, Valeria Messina, Elena Fracassi, Davide Gatti, Ombretta Viapiana, Antonio Carletto, Maurizio Rossini
Background Glucocorticoid sparing in rheumatoid arthritis (RA) treatment is crucial to minimizing adverse effects associated with long-term use. Janus kinase inhibitors (JAKi) could potentially offer a more potent glucocorticoid-sparing effect than biological Disease-Modifying Antirheumatic Drugs (bDMARDs) Material and methods This is a single-center retrospective analysis of RA patients treated with
-
Long-term efficacy of MAS825, a bispecific anti-IL1β and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS Rheumatology (IF 4.7) Pub Date : 2024-08-21 Roberta Caorsi, Arinna Bertoni, Caterina Matucci-Cerinic, Valentina Natoli, Serena Palmeri, Silvia Rosina, Federica Penco, Clara Malattia, Alessandro Consolaro, Stefania Viola, Riccardo Papa, Anna Corcione, Stefano Volpi, Angelo Ravelli, Marco Gattorno
Introduction Systemic juvenile idiopathic arthritis (sJIA), a multifaceted autoinflammatory disorder, can be complicated by life-threatening conditions such as macrophage activation syndrome (MAS) and interstitial lung disease (ILD). The management of these conditions presents a therapeutic challenge, underscoring the need for innovative treatment approaches. Objectives to report the possible role
-
Large vessel vasculitis is a risk factor for relapse only in giant cell arteritis patients without polymyalgia rheumatica Rheumatology (IF 4.7) Pub Date : 2024-08-20 Lien Moreel, Albrecht Betrains, Lennert Boeckxstaens, Geert Molenberghs, Koen Van Laere, Ellen De Langhe, Steven Vanderschueren, Daniel Blockmans
Objectives To evaluate differences in presentation and outcome of giant cell arteritis (GCA) patients with and without large vessel vasculitis (LVV) and according to the extent and severity of LVV. Methods Consecutive patients diagnosed with GCA between 2003 and 2020 who have had FDG PET imaging at diagnosis ≤3 days after initiation of glucocorticoids and followed for ≥12 months at the University Hospitals
-
Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors Rheumatology (IF 4.7) Pub Date : 2024-08-16 Theodoros Androutsakos, Konstantinos Dimitriadis, Maria-Loukia Koutsompina, Konstantinos D Vassilakis, Avraam Pouliakis, George E Fragoulis
Objectives Hepatitis B reactivation (HBVr) constitutes a side effect of the treatment of autoimmune rheumatic diseases. Even though HBVr risk of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) and anti-tumor necrosis factor (anti-TNF) agents has long been established, the risk of targeted synthetic (ts)DMARDs and anti-interleukin (anti-IL) agents remains largely unknown. Methods
-
Factors associated with long-term opioid use among patients with axial spondyloarthritis or psoriatic arthritis who initiated opioids Rheumatology (IF 4.7) Pub Date : 2024-08-16 Yun-Ting Huang, David A Jenkins, Belay Birlie Yimer, Meghna Jani
Objective Up to one in five patients with axial spondyloarthritis (AxSpA) or psoriatic arthritis (PsA) newly initiated on opioids transition to long-term use within the first year. This study aimed to investigate individual factors associated with long-term opioid use among opioid new users with AxSpA/PsA. Methods Adult patients with AxSpA/PsA and without prior cancer who initiated opioids between
-
Evaluation of changes in cardiac longitudinal strain rate in patients with systemic sclerosis undergoing iloprost treatment: an observational study Rheumatology (IF 4.7) Pub Date : 2024-08-16 Ivan Isaia, Paola Aparo, Federica Castelletti, Matteo Regolo, Maria Letizia Aprile, Paolo Fiorenza, Gianluca Sambataro, Lorenzo Malatino, Michele Colaci
Objectives Systemic Sclerosis (SSc) is characterized by widespread microangiopathy and fibrosis of skin and visceral organs. Left ventricle involvement is usually subclinical, characterized by systolic and/or diastolic dysfunction. The global longitudinal strain (GLS), a validated and reliable technique for the measurement of ventricular longitudinal deformation by means of echocardiography, may detect
-
Subclinical psoriatic arthritis and disease interception—where are we in 2024? Rheumatology (IF 4.7) Pub Date : 2024-08-16 Clementina López-Medina, Dennis McGonagle, Laure Gossec
Psoriatic arthritis (PsA) is a chronic rheumatic disease that usually appears in patients with skin psoriasis, making it a model for detection of joint disease in the pre-clinical phases in a setting where therapy for cutaneous disease may ameliorate or prevent arthritis development. Such PsA prevention appears credible due to the increasingly recognized closely shared immunopathology between the skin
-
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study Rheumatology (IF 4.7) Pub Date : 2024-08-16 Francesco Muratore, Chiara Marvisi, Giulia Cassone, Caterina Ricordi, Luigi Boiardi, Pamela Mancuso, Giulia Besutti, Lucia Spaggiari, Massimiliano Casali, Stefania Croci, Rexhep Durmo, Annibale Versari, Gabriella Di Tommaso, Mariagrazia Catanoso, Paolo Giorgi Rossi, Carlo Salvarani
Objectives To assess the maintenance of efficacy of one year of tocilizumab (TCZ) monotherapy after its discontinuation in large vessel-GCA (LV-GCA). Methods 17 patients with active LV-GCA were previously treated with 3 boluses of intravenous methylprednisone and weekly subcutaneous TCZ in monotherapy for 52 weeks. Patients in relapse-free clinical remission at week 52 discontinued TCZ and entered
-
The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus Rheumatology (IF 4.7) Pub Date : 2024-08-14 Katie Liao, Ning Li, Julie Bonin, Rachel Koelmeyer, Joanna Kent, Rebecca Pellicano, Thilinie De Silva, Kristy Yap, Vera Golder, A Richard Kitching, Eric F Morand, Alberta Hoi
Objectives Anti-Ro60 and anti-Ro52 autoantibodies are frequently used as diagnostic biomarkers for Sjogren’s disease, but their clinical significance in systemic lupus erythematosus (SLE) is not well characterised. Methods Patients fulfilling SLE classification criteria were studied according to their anti-Ro status. We defined Ro positivity (Ro+) as those who have either anti-Ro60 or anti-Ro52 positivity
-
Longitudinal analysis of serum urate in prediabetic phase Rheumatology (IF 4.7) Pub Date : 2024-08-13 Javier Marrugo, Leah M Santacroce, Misti L Paudel, Sho Fukui, Sara K Tedeschi, Daniel H Solomon
Objectives Despite the well-established association between prediabetes and hyperuricaemia, knowledge about serum urate (SU) trends during the prediabetic phase is limited. Therefore, we aimed to assess the longitudinal changes of SU in individuals with prediabetes. Methods Individuals with prediabetes, defined by initial haemoglobin A1c (HbA1c) levels between 5.7% and 6.4%, were identified using electronic
-
Transiently increased circulating CD39+FoxP3+ Treg cells predict the clinical response to Methotrexate in Early Rheumatoid Arthritis Rheumatology (IF 4.7) Pub Date : 2024-08-13 Alejandro Villalba, Laura Nuño, Marta Benito-Miguel, Beatriz Nieto-Carvalhal, Irene Monjo, Marta Novella-Navarro, Diana Peiteado, Sara García-Carazo, Alejandro Balsa, María-Eugenia Miranda-Carús
OBJECTIVES A subset of human circulating FoxP3+ regulatory T cells expresses CD39 (cTreg39+) and hydrolyses pro-inflammatory adenine nucleotides released at inflammatory foci, rendering the anti-inflammatory agent adenosine. Methotrexate (MTX), inhibiting ATIC, enhances the extrusion of adenine nucleotides and may help Treg39+ cells control inflammation. Therefore, we examined the relation of cTreg39+
-
Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions Rheumatology (IF 4.7) Pub Date : 2024-08-13 Noémie Le Gouellec, Louai Zaidan, Benjamin Chaigne, Baptiste Periou, Emeline Cailliau, Robin Dhote, Sebastien Riviere, Yurdagul Uzunhan, Christian Agard, Bertrand Godeau, Pierre Wolkenstein, Eric Hachulla, Luc Mouthon, Jerome Authier
Objectives The aim of this study was to determine the association between different histological patterns and prognosis in patients with SSc and histologically proven muscle involvement. Methods A multicentre retrospective study was conducted of a cohort of scleroderma patients who had undergone muscle biopsy. The biopsies were reviewed in a coordinated manner to classify patients based on histological
-
Systemic sclerosis and cancer in the UK: An epidemiological analysis using the Clinical Practice Research Datalink Rheumatology (IF 4.7) Pub Date : 2024-08-13 John D Pauling, Neil J McHugh, Anita McGrogan
Background Cancer can cause mortality in systemic sclerosis (SSc). We investigated the association between cancer and SSc using the Clinical Practice Research Datalink (CPRD). Methods A validated case-ascertainment strategy identified SSc patients in the CPRD. A cohort study design examined cancer occurrence following SSc, with SSc patients matched to six non-SSc comparators by age, sex and GP-practice
-
Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol Rheumatology (IF 4.7) Pub Date : 2024-08-12 Niamh C Fanning, Murray Cadzow, Ruth K Topless, Chris Frampton, Nicola Dalbeth, Tony R Merriman, Lisa K Stamp
Objectives The minor allele of the common rs2231142 ABCG2 variant predicts inadequate response to allopurinol urate lowering therapy. We hypothesize that additional variants in genes encoding urate transporters and allopurinol-to-oxypurinol metabolic enzymes also predict allopurinol response. Methods This study included a subset of participants with gout from the Long-term Allopurinol Safety Study
-
Definitions of and Instruments for Disease Activity, Remission, and Relapse in Polymyalgia Rheumatica: A Systematic Literature Review Rheumatology (IF 4.7) Pub Date : 2024-08-12 Thomas E Bolhuis, Philipp Bosch, Louise Falzon, Claire E Owen, Max Yates, Sarah L Mackie, Aatke van der Maas, Christian Dejaco
OBJECTIVE To perform a systematic literature review on definitions and instruments used to measure remission, relapse, and disease activity in polymyalgia rheumatica (PMR), to inform an OMERACT project to endorse instruments for these outcomes. METHODS A search of Pubmed/MEDLINE, EMBASE, CINAHL, Cochrane, and Epistemonikos was performed May 2021 and updated August 2023. Qualitative and quantitative
-
Short and Long-Term Outcomes of Patients with Pure Membranous Lupus Nephritis Compared to Patients with Proliferative Disease Rheumatology (IF 4.7) Pub Date : 2024-08-10 Fadi Kharouf, Qixuan Li, Laura P Whittall Garcia, Arenn Jauhal, Dafna D Gladman, Zahi Touma
Objectives Membranous lupus nephritis (MLN) is thought to have a more benign course than proliferative lupus nephritis (PLN). We aimed to determine the differences in short and long-term outcomes between patients with MLN and PLN. Methods We included patients with first biopsy-proven MLN and PLN. Short-term outcomes included complete proteinuria recovery (CPR), complete renal response (CRR), and primary
-
A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment Rheumatology (IF 4.7) Pub Date : 2024-08-09 Atul Deodhar, Alan J Kivitz, Marina Magrey, Jessica A Walsh, Philip J Mease, Maria Greenwald, Farid Kianifard, Chelsea Elam, Gopi M Bommidi, Adam Winseck, Lianne S Gensler
Objective To investigate the clinical response at week 52 in patients with ankylosing spondylitis (AS) who received secukinumab 300 vs 150 mg after inadequate response to 150 mg at week 16. Methods ASLeap (NCT03350815) was a randomized, double-blind, parallel-group, multicentre, phase 4 trial. After 16 weeks of open-label secukinumab 150 mg (Treatment Period 1), patients who did not achieve inactive
-
A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA Rheumatology (IF 4.7) Pub Date : 2024-08-09 Klára Prajzlerová, Olga Kryštůfková, Nikola Kaspříková, Nora Růžičková, Hana Hulejová, Petra Hánová, Jiří Vencovský, Ladislav Šenolt, Mária Filková
Background The presence of ACPA significantly increases the risk of developing RA. Dysregulation of lymphocyte subpopulations was previously described in RA. Our objective was to propose the predictive model for progression to clinical arthritis based on peripheral lymphocyte subsets and ACPA in individuals who are at risk of RA. Methods Our study included 207 at-risk individuals defined by the presence
-
Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosis Rheumatology (IF 4.7) Pub Date : 2024-08-09 Ann-Marcia C Tukpah, Jonathan A Rose, Diane L Seger, Paul F Dellaripa, Gary Matthew Hunninghake, David W Bates
Objective Racial and ethnic differences in presentation and outcomes have been reported in systemic sclerosis (SSc) and SSc-interstitial lung disease (ILD). However, prior studies have limited diversity. We aim to evaluate if there are racial/ethnic differences associated with ILD, time intervals between SSc and ILD and with emergency department (ED) visit or hospitalization rates. Methods Clinical
-
Epidemiology of ANCA vasculitis in Northern Spain Rheumatology (IF 4.7) Pub Date : 2024-08-07 Fabricio Benavides-Villanueva, Alba Herrero-Morant, Diana Prieto-Peña, Salma Al Fazazi, Vanesa Calvo-Río, Mónica Renuncio-García, Adrián Martín-Gutierrez, María del Amparo Sánchez-Lopez, Claudia Poo-Fernandez, Clara Escagedo-Cagigas, María Rodríguez-Vidriales, Ricardo Blanco
Objectives The incidence of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) shows disparate results due to variable classification criteria and heterogeneous-population series. We aimed to estimate the incidence of AAV in a well-defined population with standardized classification criteria. Methods Population-based study of AAV patients diagnosed from January 2000 to December
-
Tendon involvement and its association with pain and hand function in patients with osteoarthritis of the hand Rheumatology (IF 4.7) Pub Date : 2024-08-07 Irina Gessl, Anna Vinatzer, Gabriela Supp, Michael Zauner, Martina Durechova, Lisa Lechner, Valentin Ritschl, Josef Smolen, Tanja Stamm, Daniel Aletaha, Peter Mandl
Objective To characterise the frequency and influence of tenosynovitis and tendon damage on pain and hand function using clinical examination and ultrasound (US) in hand osteoarthritis (HOA). Methods We included 86 patients with HOA and 23 age- and sex-matched control subjects. Extensor and flexor tendons of both hands were assessed by clinical examination and US for tenosynovitis, tendon damage. Conventional
-
Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression Rheumatology (IF 4.7) Pub Date : 2024-08-07 Maria G Tektonidou, Kleio-Maria Verrou, Harikleia Gakiopoulou, Menelaos Manoloukos, Panagiotis Lembessis, Pantelis Hatzis, Petros P Sfikakis
Objective Pathogenesis of antiphospholipid syndrome (APS) remains poorly elucidated. We aimed to evaluate for the first time kidney transcriptome profiles in primary APS vs systemic lupus erythematosus (SLE) and control subjects. Methods We performed RNA sequencing on archival formalin-fixed paraffin-embedded kidney biopsies from APS (n = 4), SLE (n = 5) and control (n = 3) individuals, differential
-
Association of rare single nucleotide variant MUC5B rs35705950 with interstitial lung disease in Japanese rheumatoid arthritis Rheumatology (IF 4.7) Pub Date : 2024-08-07 Takashi Higuchi, Shomi Oka, Kota Shimada, Shinichiro Tsunoda, Satoshi Ito, Akira Okamoto, Misuzu Fujimori, Tadashi Nakamura, Masao Katayama, Michita Suzuki, Koichiro Saisho, Satoshi Shinohara, Toshihiro Matsui, Kiyoshi Migita, Shouhei Nagaoka, Shigeto Tohma, Hiroshi Furukawa
Objectives Rheumatoid arthritis (RA) is sometimes complicated by interstitial lung disease (ILD) with a poor prognosis. A single nucleotide variant (SNV) in MUC5B was associated with ILD in European RA patients. However, associations of this SNV were not found in Japanese RA patients, because its frequency in Japanese populations is very low. We investigated the associations of candidate SNVs including
-
De novo manifestations during adalimumab treatment in Behçet’s syndrome Rheumatology (IF 4.7) Pub Date : 2024-08-07 Sinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, Elif Kaymaz, Yesim Ozguler, Serdal Ugurlu, Emire Seyahi, Melike Melikoglu, Izzet Fresko, Vedat Hamuryudan, Ugur Uygunoglu, Zekayi Kutlubay, Ali Ibrahim Hatemi, Aykut Ferhat Celik, Gulen Hatemi
Objectives Treatment response may be variable across organ manifestations of Behçet syndrome (BS). We aimed to determine the frequency of de novo manifestations during adalimumab treatment. Methods We conducted a chart review of all BS patients who received adalimumab in our center between 2008 and 2023. Demographic data, reasons for initiating adalimumab, concurrent medications, previous treatments
-
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study Rheumatology (IF 4.7) Pub Date : 2024-08-07 Chrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, Katerina Chavatza, Evangelia Argyriou, Alexandros Panagiotopoulos, Anastasios Karamanakos, Aikaterini Dimouli, Christina Tsalapaki, Konstantinos Thomas, Philippos Orfanos, Pagona Lagiou, George Katsikas, Kyriaki Boki, Dimitrios Boumpas, Dimitrios Petras, Dimitrios Vassilopoulos
Objectives There are limited real-life data regarding the efficacy and safety of rituximab (RTX) as a remission-maintenance agent in microscopic-polyangiitis (ΜPA) and granulomatosis-with-polyangiitis (GPA). We aimed to estimate the incidence and risk factors for relapses, as well serious-adverse-events (SAEs) in MPA/GPA patients during RTX-maintenance. Methods Retrospective cohort of newly-diagnosed/relapsing
-
CT-based comprehensive scoring system for assessing hip arthropathy in ankylosing spondylitis: feasibility study with clinical correlation Rheumatology (IF 4.7) Pub Date : 2024-08-07 Flavio Duarte Silva, Alipio G Ormond Filho, Thauana L de Oliveira, Dhilip Andrew, Avneesh Chhabra, Marcelo M Pinheiro, Yin Xi, Artur da Rocha Correa Fernandes, Marcelo A C Nico, Andre Y Aihara
Objective To develop a CT-based scoring system for assessment of hip arthropathy in AS. Methods All AS patients were prospectively recruited, consented, and underwent whole-body stereoradiographs and pelvis CT, which were assessed by two independent radiologists. Stereoradiographs were assessed according to Kellgreen-Lawrence and BASRI-h. For the Hip arthropathy CT score in AS (HACTSAS), joints were
-
Changes of cerebral structure and perfusion in subtypes of systemic sclerosis: a brain magnetic resonance imaging study Rheumatology (IF 4.7) Pub Date : 2024-08-05 Xinyu Tong, Huilin He, Shihan Xu, Rui Shen, Zihan Ning, Xiaofeng Zeng, Qian Wang, Zuo-Xiang He, Dong Xu, Xihai Zhao
Objectives The characteristics of brain impairment in different subtypes of systemic sclerosis (SSc) (dcSSc, diffuse cutaneous SSc; lcSSc, limited cutaneous SSc) remain unclear. This study aimed to characterize cerebral structure and perfusion changes in different subtype of SSc patients using magnetic resonance (MR) imaging. Methods Seventy SSc patients (46.0 ± 11.7 years, 62 females) and 30 healthy
-
Severe haematological involvement in children with systemic lupus erythematosus and clinical associations Rheumatology (IF 4.7) Pub Date : 2024-08-02 Hakan Kisaoglu, Seher Sener, Kaan Can Demirbas, Yasemin Demir Yigit, Pinar Garipcin, Serkan Coşkun, Hatice Melisa Kacmaz, Rabia Miray Kisla Ekinci, Kubra Ozturk, Oya Koker, Kubra Ucak, Serife Tuncez, Gulsah Kilbas, Nihal Karacayir, Gulcan Ozomay Baykal, Sema Nur Taskın, Burcu Bozkaya, Ozge Baba, Selcan Demir, Ozge Basaran, Sezgin Sahin, Esra Baglan, Nihal Sahin, Vildan Gungorer, Aysenur Pac Kısaarslan
Objectives To investigate the severe haematological involvement in children with SLE and assess its clinical associations, treatments, outcome and damage accrual. Methods The medical charts of children with SLE in whom haematological involvement was observed were reviewed. Severe haematological indices were defined as autoimmune haemolytic anaemia with a haemoglobin concentration < 8 g/dL, thrombocyte
-
Positive and negative controls in rheumatology research Rheumatology (IF 4.7) Pub Date : 2024-08-02 Adam Kelly, Kylie Carlson, Zach Wallace, Michael Putman
Observational research from large population databases may be affected by unmeasured confounding and time-related biases, such as immortal time bias. Modern causal inference practice applies propensity score-based methods, new-user designs, and other strategies to mitigate bias. The degree to which these methodologic approaches adequately address bias for any particular study may be difficult to measure
-
ANA-arthritis: clinical and biomarker characterization of a population for basket trials Rheumatology (IF 4.7) Pub Date : 2024-08-01 Jack Arnold, Lucy M Carter, Md Yuzaiful Md Yusof, Katie Dutton, Zoe Wigston, Shouvik Dass, Samuel Wood, Samuel Relton, Edward M Vital
Objectives ANA-associated RMDs (ANA-RMDs—SLE, pSS, scleroderma, inflammatory myositis, mixed connective tissue disease (MCTD) and undifferentiated connective tissue disease) are a disease spectrum with overlapping clinical and immunological features. Musculoskeletal inflammation is common and impactful across ANA-RMDs. We evaluated musculoskeletal inflammation (ANA-arthritis) prevalence in a multi-disease
-
Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: A systematic literature review Rheumatology (IF 4.7) Pub Date : 2024-08-01 Koushan Kouranloo, Mrinalini Dey, Helen Elwell, Veronica Yioe, Lisa G Spencer, Caroline V Cotton
Background Anti-synthetase syndrome (ASS) is a chronic autoimmune condition, with interstitial lung disease (ILD) being a key feature. This systematic literature review (SLR; CRD42023416414) aimed to summarise treatments and outcomes of ILD associated with ASS (ASS-ILD). Methods Databases were searched for articles discussing ASS-ILD management and outcomes, published 1946-September 2023. Screening
-
Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis Rheumatology (IF 4.7) Pub Date : 2024-07-30 Monica Leu Agelii, Outi Sareila, Erik Lönnblom, Lei Cheng, Kristina Forslind, Ingiäld Hafström, Maria Andersson, Alf Kastbom, Christopher Sjöwall, Lennart T H Jacobsson, Jan Kihlberg, Rikard Holmdahl, Inger Gjertsson
Objective For better management of rheumatoid arthritis (RA), new biomarkers are needed to predict the development of different disease courses. This study aims to identify autoantibodies against epitopes on proteins in the joints and to predict disease outcome in patients with new onset RA. Methods Sera from new onset RA patients from the Swedish BARFOT and TIRA-2 cohorts (n = 1986) were screened